Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07244510 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa (HS)

Interventions

DRUG: SCT650C

Sponsor

Sinocelltech Ltd.